Severe PPH (≥ 1000 mL) · management of retained placenta
Oxytocin solution showed no clear difference in severe PPH (≥ 1000 mL) compared with saline solution (moderate certainty).
1 finding from 1 review
Blood transfusion · management of retained placenta
Oxytocin solution showed no clear difference in blood transfusion compared with saline solution (moderate certainty).
1 finding from 1 review
Addition of therapeutic uterotonics · management of retained placenta
Oxytocin solution showed no clear difference in addition of therapeutic uterotonics compared with saline solution (low certainty).
1 finding from 1 review
Need for antibiotics · management of retained placenta
Oxytocin solution showed no clear difference in need for treatment with antibiotics (infection) compared with saline solution (moderate certainty).
1 finding from 1 review
Maternal postpartum anaemia (haemoglobin 24–48 hours postpartum) · management of retained placenta
1 finding from 1 review
Manual removal of the placenta · management of retained placenta
It is very uncertain whether oxytocin solution changes manual removal of the placenta compared with plasma expander (very low certainty).
1 finding from 1 review
Maternal death · management of retained placenta
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe PPH (≥ 1000 mL) · management of retained placenta
It is very uncertain whether oxytocin solution changes severe PPH (≥ 1000 mL) compared with plasma expander (very low certainty).
1 finding from 1 review
Blood transfusion · management of retained placenta
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Addition of therapeutic uterotonics · management of retained placenta
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for antibiotics · management of retained placenta
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal postpartum anaemia (haemoglobin 24–48 hours postpartum) · management of retained placenta
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Manual removal of the placenta · management of retained placenta
Oxytocin solution may leads to lower manual removal of the placenta compared with expectant management (low certainty).
1 finding from 1 review
Maternal death · management of retained placenta
1 finding from 1 review
Oxytocin augmentation · women in the third trimester for induction of labour.
Oral misoprostol may leads to lower oxytocin augmentation compared with intravenous oxytocin (low certainty).
1 finding from 1 review
Severe postpartum haemorrhage · pregnant women giving birth in non‐facility settings
It is very uncertain whether prophylactic oxytocin injection (delivered by community health… changes severe postpartum haemorrhage (> 1000 mL) [ compared with control (no injection) (very low certainty).
1 finding from 1 review
Severe maternal morbidity · pregnant women giving birth in non‐facility settings
1 finding from 1 review
Maternal death · pregnant women giving birth in non‐facility settings
1 finding from 1 review
Postpartum haemorrhage · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… may leads to lower postpartum haemorrhage (PPH greater or equal to 500 mL) [ compared with control (no injection) (low certainty).
2 findings from 1 review
Maternal transfer or referral to a health facility · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… showed no clear difference in transfer or referral to health facility [ compared with control (no injection) (low certainty).
1 finding from 1 review